Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1
This minimizes out-of-pocket expenses compared to paying for Mounjaro without sufficient insurance aid
Learn more about eligibility and how to submit an application by Friday, Feb
This is especially important if you have any health issues, are pregnant or breastfeeding, or take other medicines
And for a good reason the benefits of BPC-157 are quickly making it one of the most sought-after health supplements around